---
figid: PMC4107712__10.1177_1758834014530023-fig1
figtitle: Illustration of the PI3K/Akt/mTOR pathway
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4107712
filename: 10.1177_1758834014530023-fig1.jpg
figlink: /pmc/articles/PMC4107712/figure/fig1-1758834014530023/
number: F1
caption: Illustration of the PI3K/Akt/mTOR pathway. The PI3K/Akt/mTOR pathway is a
  major intracellular network that leads to cell proliferation. The activation of
  Akt inhibits TSC, which acts as a GTPase activating protein for Rheb. mTORC1 stimulates
  protein synthesis, metabolism and cell growth via modulation of S6K1 and 4EBP1.
  mTORC2 activates Akt, which then inhibits the proteolysis of Cyclin D1/E. PTEN and
  TSC are significant tumor suppressors (shown in green). 4EBP1, eukaryotic initiation
  factor 4E binding protein 1; Akt, protein kinase B; Glut1, glucose transporter 1;
  GTPase, guanosine triphosphatase; HIF-1, hypoxia inducible factor 1; IRS, insulin
  receptor substrate; mTORC1/2, mammalian target of rapamycin complex 1/2; PI3K, phosphatidylinositol
  3 kinase; PTEN, phosphatase and tensin homolog; S6K1, S6 kinase 1; TSC, tuberous
  sclerosis.
papertitle: 'The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers.'
reftext: Elisavet Paplomata, et al. Ther Adv Med Oncol. 2014 Jul;6(4):154-166.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9658916
figid_alias: PMC4107712__F1
figtype: Figure
redirect_from: /figures/PMC4107712__F1
ndex: a3e0ef1c-ded1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4107712__10.1177_1758834014530023-fig1.html
  '@type': Dataset
  description: Illustration of the PI3K/Akt/mTOR pathway. The PI3K/Akt/mTOR pathway
    is a major intracellular network that leads to cell proliferation. The activation
    of Akt inhibits TSC, which acts as a GTPase activating protein for Rheb. mTORC1
    stimulates protein synthesis, metabolism and cell growth via modulation of S6K1
    and 4EBP1. mTORC2 activates Akt, which then inhibits the proteolysis of Cyclin
    D1/E. PTEN and TSC are significant tumor suppressors (shown in green). 4EBP1,
    eukaryotic initiation factor 4E binding protein 1; Akt, protein kinase B; Glut1,
    glucose transporter 1; GTPase, guanosine triphosphatase; HIF-1, hypoxia inducible
    factor 1; IRS, insulin receptor substrate; mTORC1/2, mammalian target of rapamycin
    complex 1/2; PI3K, phosphatidylinositol 3 kinase; PTEN, phosphatase and tensin
    homolog; S6K1, S6 kinase 1; TSC, tuberous sclerosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB3
  - EGFR
  - IGF1R
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - PTEN
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - DEPTOR
  - RPTOR
  - TSC2
  - TSC1
  - CCL26
  - SLC12A3
  - TESC
  - AKT1S1
  - RHEB
  - RHEBP1
  - RPS6KB1
  - EIF4EBP1
  - SETD2
  - SLC2A1
  - Egfr
  - IRSp53
  - IleRS
  - chico
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk1
  - Pten
  - rictor
  - Mtor
  - Tor
  - Akt
  - Crtc
  - gig
  - Tsc1
  - Tsc
  - raptor
  - PRAS40
  - Rheb
  - S6k
  - Thor
  - tgo
  - sima
  - Glut1
  - Cancer
---
